Tracy Tomlinson, a 58-year-old patient with advanced ovarian cancer, has become the first in the world to receive the new cell therapy ZI-MA4-1, an experimental treatment designed to address various types of solid tumors, with the aim of not only improving her own life but also contributing to the advancement of research to help other patients. (translated)
